A detailed history of Opaleye Management Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Opaleye Management Inc. holds 325,000 shares of LQDA stock, worth $3.58 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
325,000
Previous 395,000 17.72%
Holding current value
$3.58 Million
Previous $5.83 Million 33.06%
% of portfolio
1.0%
Previous 1.42%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $837,200 - $1.1 Million
-70,000 Reduced 17.72%
325,000 $3.9 Million
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $567,500 - $836,500
-50,000 Reduced 11.24%
395,000 $5.83 Million
Q4 2023

Feb 14, 2024

SELL
$5.77 - $12.19 $725,289 - $1.53 Million
-125,700 Reduced 22.03%
445,000 $5.35 Million
Q2 2023

Aug 14, 2023

SELL
$6.63 - $9.9 $29,835 - $44,550
-4,500 Reduced 0.78%
570,700 $4.48 Million
Q1 2023

May 12, 2023

BUY
$5.72 - $7.91 $86,944 - $120,232
15,200 Added 2.71%
575,200 $3.97 Million
Q4 2022

Feb 10, 2023

SELL
$4.68 - $6.54 $16,379 - $22,890
-3,500 Reduced 0.62%
560,000 $3.57 Million
Q3 2022

Nov 14, 2022

BUY
$3.73 - $8.39 $156,660 - $352,380
42,000 Added 8.05%
563,500 $3.07 Million
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $1.15 Million - $2.59 Million
342,700 Added 191.67%
521,500 $2.27 Million
Q1 2022

May 16, 2022

BUY
$5.14 - $7.38 $832,680 - $1.2 Million
162,000 Added 964.29%
178,800 $1.28 Million
Q4 2021

Feb 14, 2022

BUY
$2.71 - $5.17 $45,528 - $86,856
16,800 New
16,800 $82,000
Q3 2020

Nov 16, 2020

SELL
$4.34 - $8.28 $1.74 Million - $3.31 Million
-400,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.86 - $11.44 $1.94 Million - $4.58 Million
400,000 New
400,000 $3.37 Million
Q2 2019

Aug 14, 2019

SELL
$7.92 - $11.39 $1.78 Million - $2.56 Million
-225,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.82 - $21.79 $2.43 Million - $4.9 Million
225,000 New
225,000 $2.56 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.